M.J.M. (Ron) Smits, PhD

Ron Smits studied Biomedical Sciences at the University of Leiden, The Netherlands (1985-1992), where he also performed his PhD study and Postdoctoral training at the Department of Human Genetics. His thesis entitled "APC and cancer: It takes two to tango" was successfully defended in 2002 (cum laude). Beginning of 2003, he joined Genentech Inc., South San Francisco, CA, as a research scientist. Here, he also developed the research line to investigate the cross-talk between receptor tyrosine kinases and β-catenin signaling in cancer for which he was awarded a Vidi (ZonMW) grant in 2004, which was initiated in the Department of Pathology of the Erasmus MC in Rotterdam, The Netherlands. Since January 2008, he is a staff member at the Department of Gastroenterology and Hepatology of the Erasmus MC. Our current research focusses on molecular mechanisms contributing to intestinal and hepatocellular tumor formation and metastasis, with a special focus on the role played by Wnt/β-catenin signaling. 

2008 to date Staff member/Assistant Professor, Dept. of Gastroenterology & Hepatology, Erasmus MC 
2004-2007 Assistant Professor, Dept. of Pathology, Josephine Nefkens Institute, Erasmus MC 
2003-2004 Research Scientist, Genentech, Inc., South San Francisco, CA.
1998-2002 Post-doc, Dept. of Human Genetics, University of Leiden, The Netherlands. 
1994-1998 PhD-student, Dept. of Human Genetics, University of Leiden, The Netherlands. Cum laude, January 24, 2002.

https://www.ncbi.nlm.nih.gov/

https://www.scopus.com/authid/detail.uri?authorId=7005330248

Teacher for Bachelor of Clinical Technology (TU Delft/Erasmus MC/Leiden University

Supervised theses

• Jul 2008-Oct 2012: Lalini Raghoebir; Balancing on Sox: Involvement of Sox2 in determination and maintenance of organ identity of the gastrointestinal tract
• Jun 2008-Dec 2012: Elvira Bakker;  Novel Aspects of Wnt Signaling in intestinal development and cancer
• Sept 2013-June 2018: Wenhui Wang; Targeting Wnt/β-catenin signaling in Liver Cancers
• Sept 2015-June 2019: Pengyu Liu; The mutant components of Wnt/β-catenin signaling in liver cancer
• Jan 2015-Aug 2020: Shan Li: Microbiome and Molecular Characterization of Neoplasms in Pancreas and Intestine
• Oct 2018-Oct 2023: Ruyi Zhang: Exploring the Contribution of AXIN1 Mutation and tRNA Biology to Liver Cancer

NWO Dutch Research Council VIDI 2004-09: Cross-talk between receptor tyrosine kinases and ß-catenin signaling during tumor initiation and progression.

KWF Dutch Cancer Society 2005-2010: Cross-talk between receptor tyrosine kinases and β-catenin signaling in colorectal cancer. 

Erasmus MC PhD grant 2016-2020: Unraveling mechanisms controlling mucus production in colorectal cancer: A prominent role for ATOH1.

Erasmus MC PhD grant 2008-2012: The role of SOX2 in intestinal development and the formation of mucinous colorectal cancer. 

Erasmus MC pilot grant 2012-2014: Transcriptional read-through as mechanism to explain the CpG island methylator phenotype of colorectal cancer.